|
CL2025003637A1
(es)
|
|
Anticuerpos anti-tgf-beta 1 latente y métodos de uso.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BY13170U
(https=)
|
|
|
|
BY13176U
(https=)
|
|
|
|
CN307049392S
(https=)
|
|
|
|
CN307049387S
(https=)
|
|
|
|
CN307048894S
(https=)
|
|
|
|
CN307048422S
(https=)
|
|
|
|
CN307047236S
(https=)
|
|
|
|
CN307047177S
(https=)
|
|
|
|
CN307046813S
(https=)
|
|
|
|
CN307046197S
(https=)
|
|
|
|
CN307045496S
(https=)
|
|
|
|
CN307045382S
(https=)
|
|
|
|
CN307044957S
(https=)
|
|
|
|
BY13165U
(https=)
|
|
|
|
BY13159U
(https=)
|
|
|
|
BY13166U
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
BY13174U
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|
|
BY13160U
(https=)
|
|
|